Description
A DPP-4 inhibitor (IC50 = 104 nM); decreases plasma glucose levels by 46-67% in an oral glucose challenge in fasted, diabetic KK/H1J mice at 0.3-5 mg/kg; decreases plasma DPP-4 activity by approximately 50% and increases plasma GLP-1 levels in KK/H1J mice
Formal name: (2R,5S)-rel-1-[2-[[1-(hydroxymethyl)cyclopentyl]amino]acetyl]-2,5-pyrrolidinedicarbonitrile, monohydrochloride
Synonyms:
Molecular weight: 312.8
CAS: 866396-70-5
Purity: ≥98%
Formulation: A solid